Literature DB >> 25605700

NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.

Nisha Bansal1, Ronit Katz2, Lorien Dalrymple3, Ian de Boer2, Christopher DeFilippi4, Bryan Kestenbaum2, Meyeon Park5, Mark Sarnak6, Stephen Seliger7, Michael Shlipak8.   

Abstract

BACKGROUND AND OBJECTIVES: Elevations in N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T are associated with poor cardiovascular outcomes. Whether elevations in these cardiac biomarkers are associated with decline in kidney function was evaluated. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: N-terminal pro-B-type natriuretic peptide and troponin T were measured at baseline in 3752 participants free of heart failure in the Cardiovascular Health Study. eGFR was determined from the Chronic Kidney Disease Epidemiology Collaboration equation using serum cystatin C. Rapid decline in kidney function was defined as decline in serum cystatin C eGFR≥30%, and incident CKD was defined as the onset of serum cystatin C eGFR<60 among those without CKD at baseline (n=2786). Cox regression models were used to examine the associations of each biomarker with kidney function decline adjusting for demographics, baseline serum cystatin C eGFR, diabetes, and other CKD risk factors.
RESULTS: In total, 503 participants had rapid decline in serum cystatin C eGFR over a mean follow-up time of 6.41 (1.81) years, and 685 participants developed incident CKD over a mean follow-up time of 6.41 (1.74) years. Participants in the highest quartile of N-terminal pro-B-type natriuretic peptide (>237 pg/ml) had an 67% higher risk of rapid decline and 38% higher adjusted risk of incident CKD compared with participants in the lowest quartile (adjusted hazard ratio for serum cystatin C eGFR rapid decline, 1.67; 95% confidence interval, 1.25 to 2.23; hazard ratio for incident CKD, 1.38; 95% confidence interval, 1.08 to 1.76). Participants in the highest category of troponin T (>10.58 pg/ml) had 80% greater risk of rapid decline compared with participants in the lowest category (adjusted hazard ratio, 1.80; 95% confidence interval, 1.35 to 2.40). The association of troponin T with incident CKD was not statistically significant (hazard ratio, 1.17; 95% confidence interval, 0.92 to 1.50).
CONCLUSIONS: Elevated N-terminal pro-B-type natriuretic peptide and troponin T are associated with rapid decline of kidney function and incident CKD. Additional studies are needed to evaluate the mechanisms that may explain this association.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  CKD; epidemiology and outcomes; heart disease

Mesh:

Substances:

Year:  2015        PMID: 25605700      PMCID: PMC4317737          DOI: 10.2215/CJN.04910514

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  47 in total

1.  Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.

Authors:  Lori B Daniels; Gail A Laughlin; Paul Clopton; Alan S Maisel; Elizabeth Barrett-Connor
Journal:  J Am Coll Cardiol       Date:  2008-08-05       Impact factor: 24.094

2.  Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.

Authors:  Wilfried Mullens; Zuheir Abrahams; Gary S Francis; George Sokos; David O Taylor; Randall C Starling; James B Young; W H Wilson Tang
Journal:  J Am Coll Cardiol       Date:  2009-02-17       Impact factor: 24.094

3.  Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects.

Authors:  Roland R J van Kimmenade; James L Januzzi; Jaap A Bakker; Alphonse J Houben; Roger Rennenberg; Abraham A Kroon; Harry J G M Crijns; Marja P van Dieijen-Visser; Peter W de Leeuw; Yigal M Pinto
Journal:  J Am Coll Cardiol       Date:  2009-03-10       Impact factor: 24.094

4.  Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.

Authors:  Björn Zethelius; Lars Berglund; Johan Sundström; Erik Ingelsson; Samar Basu; Anders Larsson; Per Venge; Johan Arnlöv
Journal:  N Engl J Med       Date:  2008-05-15       Impact factor: 91.245

5.  Clinical and subclinical cardiovascular disease and kidney function decline in the elderly.

Authors:  Michael G Shlipak; Ronit Katz; Bryan Kestenbaum; Linda F Fried; David Siscovick; Mark J Sarnak
Journal:  Atherosclerosis       Date:  2008-08-26       Impact factor: 5.162

6.  The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study.

Authors:  Irene Betti; Gabriele Castelli; Alessandro Barchielli; Cinzia Beligni; Vittorio Boscherini; Leonardo De Luca; Gianni Messeri; Mihai Gheorghiade; Alan Maisel; Alfredo Zuppiroli
Journal:  J Card Fail       Date:  2009-01-21       Impact factor: 5.712

7.  Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C.

Authors:  Michael G Shlipak; Ronit Katz; Bryan Kestenbaum; Linda F Fried; Anne B Newman; David S Siscovick; Lesley Stevens; Mark J Sarnak
Journal:  Am J Nephrol       Date:  2009-04-07       Impact factor: 3.754

8.  Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure.

Authors:  Takayoshi Tsutamoto; Chiho Kawahara; Masayuki Yamaji; Keizo Nishiyama; Masanori Fujii; Takashi Yamamoto; Minoru Horie
Journal:  Eur J Heart Fail       Date:  2009-06-05       Impact factor: 15.534

Review 9.  Cardiorenal syndrome.

Authors:  Claudio Ronco; Mikko Haapio; Andrew A House; Nagesh Anavekar; Rinaldo Bellomo
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

10.  Rapid kidney function decline and mortality risk in older adults.

Authors:  Dena E Rifkin; Michael G Shlipak; Ronit Katz; Linda F Fried; David Siscovick; Michel Chonchol; Anne B Newman; Mark J Sarnak
Journal:  Arch Intern Med       Date:  2008-11-10
View more
  21 in total

1.  Echocardiographic Measures and Estimated GFR Decline Among African Americans: The Jackson Heart Study.

Authors:  Leila R Zelnick; Ronit Katz; Bessie A Young; Adolfo Correa; Bryan R Kestenbaum; Ian H de Boer; Nisha Bansal
Journal:  Am J Kidney Dis       Date:  2017-01-28       Impact factor: 8.860

2.  Indication for Dialysis Initiation and Mortality in Patients With Chronic Kidney Failure: A Retrospective Cohort Study.

Authors:  Matthew B Rivara; Chang Huei Chen; Anupama Nair; Denise Cobb; Jonathan Himmelfarb; Rajnish Mehrotra
Journal:  Am J Kidney Dis       Date:  2017-01       Impact factor: 8.860

3.  Can we save the kidneys by protecting the heart?

Authors:  Srisakul Chirakarnjanakorn; W H Wilson Tang
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-20       Impact factor: 8.237

4.  High-Sensitivity Cardiac Troponin, Natriuretic Peptide, and Long-Term Risk of Acute Kidney Injury: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Junichi Ishigami; Yuhree Kim; Yingying Sang; Steven P Menez; Morgan E Grams; Hicham Skali; Amil M Shah; Ron C Hoogeveen; Elizabeth Selvin; Scott D Solomon; Christie M Ballantyne; Josef Coresh; Kunihiro Matsushita
Journal:  Clin Chem       Date:  2021-01-08       Impact factor: 8.327

5.  Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study.

Authors:  Nisha Bansal; Leila Zelnick; Michael G Shlipak; Amanda Anderson; Robert Christenson; Rajat Deo; Christopher deFilippi; Harold Feldman; James Lash; Jiang He; John Kusek; Bonnie Ky; Stephen Seliger; Elsayed Z Soliman; Alan S Go
Journal:  Clin Chem       Date:  2019-10-02       Impact factor: 8.327

6.  Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease.

Authors:  Nisha Bansal; Leila Zelnick; Zeenat Bhat; Mirela Dobre; Jiang He; James Lash; Bernard Jaar; Rupal Mehta; Dominic Raj; Hernan Rincon-Choles; Milda Saunders; Sarah Schrauben; Matthew Weir; Julie Wright; Alan S Go
Journal:  J Am Coll Cardiol       Date:  2019-06-04       Impact factor: 24.094

Review 7.  Selected cardiovascular risk factors in early stages of chronic kidney disease.

Authors:  Joanna Jagieła; Piotr Bartnicki; Jacek Rysz
Journal:  Int Urol Nephrol       Date:  2020-01-18       Impact factor: 2.370

8.  Troponin T as a Predictor of End-Stage Renal Disease and All-Cause Death in African Americans and Whites From Hypertensive Families.

Authors:  LaTonya J Hickson; Andrew D Rule; Kenneth R Butler; Gary L Schwartz; Allan S Jaffe; Adam C Bartley; Thomas H Mosley; Stephen T Turner
Journal:  Mayo Clin Proc       Date:  2015-10-19       Impact factor: 7.616

9.  Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Amanda H Anderson; Dawei Xie; Xue Wang; Robin L Baudier; Paula Orlandi; Lawrence J Appel; Laura M Dember; Jiang He; John W Kusek; James P Lash; Sankar D Navaneethan; Akinlolu Ojo; Mahboob Rahman; Jason Roy; Julia J Scialla; James H Sondheimer; Susan P Steigerwalt; F Perry Wilson; Myles Wolf; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2020-08-28       Impact factor: 8.860

10.  Advance Care Planning Documentation and Intensity of Care at the End of Life for Adults With Congestive Heart Failure, Chronic Kidney Disease, and Both Illnesses.

Authors:  Gwen M Bernacki; Cara L McDermott; Daniel D Matlock; Ann M O'Hare; Lyndia Brumback; Nisha Bansal; James N Kirkpatrick; Ruth A Engelberg; Jared Randall Curtis
Journal:  J Pain Symptom Manage       Date:  2021-08-04       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.